头支状细胞癌的年轻患者的放射治疗结果和危险因素:匹配对分析
Jiadai Zou1,2, Alexander Rühle1,2,3,4, Henning Schäfer3,4
1Department of Radiation Oncology, University of Leipzig Medical Center, Stephanstr. 9a, 04103, Leipzig, Germany.
Radiation oncology (London, England)
|April 23, 2025
概括
接受 (化疗) 放射治疗的年轻头角状细胞癌 (HNSCC) 患者的生存结果与老年患者相似. 慢性毒性很低,但长期的生活质量需要进一步调查.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 临床研究 临床研究
背景情况:
- 头皮状细胞癌 (HNSCC) 呈现出根据年龄的不同结果.
- 关于年轻HNSCC患者 (≤45岁) 的瘤结果存在相互矛盾的数据.
- 这项研究研究了年轻的HNSCC患者,他们接受了 (化疗) 放射治疗.
研究的目的:
- 分析年轻HNSCC患者的临床特征和生存率.
- 为了比较年轻 (≤45岁) 和老年 (>45岁) HNSCC 患者之间的瘤结果和治疗毒性.
- 确定影响年轻HNSCC患者生存的危险因素.
主要方法:
- 对99名HNSCC患者 ≤45岁接受放射治疗的回顾性分析 (2009-2021年).
- 根据TNM阶段和瘤部位,与45岁以上的HNSCC患者进行匹配比较.
- 评估总生存 (OS),无进展生存 (PFS),无转移生存 (DMFS),局部区域控制 (LRC) 和治疗毒性.
主要成果:
- 年轻的HNSCC患者的平均寿命为63个月.
- 在多变量分析中,每日饮酒是减少OS的重要风险因素.
- 在年轻和年长的HNSCC队列之间没有观察到PFS,LRC或DMFS的显著差异. 在年轻患者中观察到中度慢性毒性.
结论:
- 接受 (化疗) 辐射治疗的年轻HNSCC患者 (≤45岁) 获得与老年患者相比的瘤生存结果.
- 虽然慢性毒性通常很低,但长期的生活质量需要进一步探索.
- 与普通人群相比,年轻HNSCC幸存者的过度死亡风险仍然明显高.
更多相关视频
相关概念视频
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Cancer Survival Analysis
298
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
298
Skin Cancer
2.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
2.9K


